Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Sensory Organ Drugs - Southern Asia

Southern Asia
  • In Southern Asia, the Sensory Organ Drugs market is anticipated to achieve a revenue of US$302.78m by the year 2025.
  • This is projected to exhibit a steady growth rate of -5.06% annually, leading to a market volume of US$246.02m by 2029.
  • When compared globally, United States is expected to generate the highest revenue in this market, with US$14.75bn in the year 2025.
  • The demand for sensory organ drugs in Southern Asia is rapidly increasing due to the region's high prevalence of visual and auditory impairments.

Definition:
This market covers ophthalmologicals and otologicals, i.e., drugs for the sensory organs eye and ear, respectively. Ophthalmologicals are used to treat diseases of the eye such as wet age-related macular degeneration, geographic atrophy, and glaucoma. Typical dosage forms are eye drops or injections into the eye (intravitreal) and, in the case of otologicals, through the eardrum into the middle ear.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Regeneron Pharmaceuticals, Novartis, Bayer, Alcon, AbbVie

In-Scope
  • Ophthalmologicals
  • Otologicals
Out-Of-Scope
  • Respiratory system
  • Ophthalmic devices, such as diagnostic and surgical devices or glasses and contact lenses
  • Dermatology, skin treatment
  • Painkillers, analgesics
Sensory Organs Drugs: market data & analysis - Cover

Market Insights report

Sensory Organs Drugs: market data & analysis
Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update:

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update:

    Most recent update:

    Source: Statista Market Insights

    Analyst Opinion

    The Sensory Organ Drugs market in Southern Asia has been experiencing growth in recent years.

    Customer preferences:
    Customers in Southern Asia have been showing a growing interest in Sensory Organ Drugs due to the increasing prevalence of sensory organ diseases in the region. These diseases include glaucoma, cataracts, and age-related macular degeneration, among others. Additionally, the aging population in the region has also been a contributing factor to the growth of the market.

    Trends in the market:
    India has been the largest market for Sensory Organ Drugs in Southern Asia, thanks to the country's large population and high incidence of eye diseases. The country is expected to continue to dominate the market due to the increasing prevalence of diabetes, which is a major risk factor for diabetic retinopathy. The market for Sensory Organ Drugs in Pakistan and Bangladesh is also expected to grow due to the increasing incidence of eye diseases in these countries.

    Local special circumstances:
    One of the major challenges in the Sensory Organ Drugs market in Southern Asia is the lack of awareness about eye diseases and their treatment. In many cases, patients do not seek medical attention until the disease has progressed to an advanced stage, making treatment more difficult. Additionally, the high cost of treatment is also a barrier for many patients.

    Underlying macroeconomic factors:
    The Sensory Organ Drugs market in Southern Asia is expected to continue to grow due to the increasing prevalence of eye diseases in the region, as well as the aging population. However, the market is also likely to face challenges due to the lack of awareness about eye diseases and the high cost of treatment.

    Key Players

    Most recent update:

    Source: Statista Market Insights

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Sensory Organs Drugs: market data & analysis - BackgroundSensory Organs Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update:

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)